Journals / Cumhuriyet Dental Journal / 2016 / Cilt: 19 - Sayı: 3

Management of Mandibular Osteomyelitis Combined with Platelet Rich Fibrin (PRF) and Ozone

Pages
189–196
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Osteomyelitis, Ozone, Platelet rich fibrinfibrin are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteomyelitis is inflammation of bone tissue which is seen in patient with malnutrition and such systemic diseases caused by decreased resistant to infection.
📊
Key Findings & Data:Generally, chronic osteomyelitis is treated with antibiotics and surgical debridement to remove all the dead bone tissue.
💡
Conclusion & Impact:Keywords: Osteomyelitis, Ozone, Platelet rich fibrinfibrin are presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Osteomyelitis is inflammation of bone tissue which is seen in patient with malnutrition and such systemic diseases caused by decreased resistant to infection. Generally, chronic osteomyelitis is treated with antibiotics and surgical debridement to remove all the dead bone tissue. In this case report, the management of mandibular osteomyelitis which is developed after surgery and application with ozone and platelet-rich fibrin are presented. Keywords: Osteomyelitis, Ozone, Platelet rich fibrinfibrin are presented.

🔖

Cite This Article

HOCAOĞLU, T. P., TOKER, H., ALPANLEKTEMÜR, A. (2022). Management of Mandibular Osteomyelitis Combined with Platelet Rich Fibrin (PRF) and Ozone. Cumhuriyet Dental Journal, Cilt: 19 - Sayı: 3, 189–196. https://ajindex.com/articles/477076

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am 2004;86-A:2305-2318
  2. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997;336:999-1007
  3. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5:9-17
  4. Kilic B. Diagnostic methods for Osteomyelitis. Advances in Environmental Biology 2014;8:573- 581
  5. Uckay I, Jugun K, Gamulin A, Wagener J, Hoffmeyer P, Lew D. Chronic osteomyelitis. Curr Infect Dis Rep 2012;14:566-575
  6. Evans RP, Nelson, C.L., Lange, T.A. Pathophysiology of osteomyelitis. In: Surgery of the musculoskeletal system, 1990;Mc Collister Ewarts (ed):19-35
  7. Calhoun KH, Shapiro RD, Stiernberg CM, Calhoun JH, Mader JT. Osteomyelitis of the mandible. Arch Otolaryngol Head Neck Surg 1988;114:1157-1162
  8. Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg 2004;188:57-66
  9. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364:369-379
  10. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e37-44
  11. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e45-50
  12. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15
  13. Braccini F, Dohan DM. [The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): preliminary results]. Rev Laryngol Otol Rhinol (Bord) 2007;128:255- 260
  14. O'Connell SM, Impeduglia T, Hessler K, Wang XJ, Carroll RJ, Dardik H. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Repair Regen 2008;16:749- 756
  15. Azarpazhooh A, Limeback H. The application of ozone in dentistry: a systematic review of literature. J Dent 2008;36:104-116
  16. Srikanth A, Sathish M, Sri Harsha AV. Application of ozone in the treatment of periodontal disease. J Pharm Bioallied Sci 2013;5:S89-94
  17. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006;17:897-90